Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population

Nephron - Clinical Practice

Volumn 104, Issue 1, 2006, Pages

  Ammirati, Adriano Luiz ^a   Dalboni, Maria Aparecida ^a   Cendoroglo, Miguel ^a   Draibe, Sérgio Antonio ^a   Canziani, Maria Eugênia Fernandas ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Coronary arteriosclerosis; Inflammation; Peritoneal dialysis; Vascular calcification

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CALCIUM; CALCIUM PHOSPHATE; FAS ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LIPID; LOW DENSITY LIPOPROTEIN; OSTEOPROTEGERIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MALE; MINERAL METABOLISM; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC DISEASE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; C-REACTIVE PROTEIN; CALCINOSIS; CALCIUM; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PHOSPHORUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747234118     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093257     Document Type: Article

References (39)

1. US Renal Data System 1998: Annual Data Report. National Institute of Health National Institute of Diabetes Mellitus, Digestive and Kidney Disease, Bethesda, MD, USA.
2. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(suppl 1):S117-S131.
3. Wanner C, Zimmermann J, Schwedler S, Metzger T: Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002;80:99-102.
4. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
5. Arnett EM, Asner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, Roberts WC: Coronary artery narrowing in coronary heart disease: comparison of cineangiografic and necropsy findings. Ann Int Med 1979;91:109-115.
6. Knez A, Becker C, Becker A, Leber A, White C, Reiser M, Steinbeck G: Determination of coronary calcium with multi-slice spiral computed tomography: a comparative study with electron-beam CT. Int J Cardiovasc Imaging 2002;18:295-303.
7. Baumgart D, Schmermund A, Goerge G, Haude M, Ge J, Adamzik M, Sehnert C, Altmaier K, Groenemeyer D, Seibel R, Erbel R: Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J Am Coll Cardiol 1997;30:57-64.
8. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease. Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
9. Agatston AS, Jamowitz WR, Hildner FJ, Zusner NR, Viamont M, Detrano R: Quantification of coronary artery calcification using ultrafast Computed Tomography. J Am Coll Cardiol 1990;15:827-832.
10. Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74:243-252.
11. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 20;39:695-670.
12. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary- Artery calcification in young adults with end stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
13. Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E: An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003;41:203-211.
14. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
15. Fox CS, Larson MG, Keyes MJ, Levy D, Clouse ME, Culleton B, O'Donnell CJ: Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study. Kidney Int 2004;66:2017-2021.
16. Janowitz WR, Agatston AS, Kaplan G, Viamonte M Jr: Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993;72:247-254.
17. Wong ND, Kouwabunpat D, Vo AN, Detrano RC, Eisenberg H, Goel M, Tobis JM: Coronary calcium and atherosclerosis by ultrafast computed tomography ill asymptomatic men and women: relation to age and risk factors. Am Heart J 1994;127:422-430.
18. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001;21:2051-2058.
19. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001;38:64-69.
20. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG: Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 2002;106:1077-1082.
21. Goel M, Wong ND, Eisenberg H, Hagar J, Kelly K, Tobias JM: Risk factor correlates of coronary calcium as evaluated by ultrafast computed tomography. Am J Cardiol 1992;70:977-980.
22. Block GA, Hulbert-Shearon TE, Levin NN, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
23. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
24. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y: Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002;106:1192-1194.
25. Nitta K, Akiba T, Uchida K, Kawashima A, Yumura W, Kabaya T, Nihei H: The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 2003;42:303-309.
26. Browner WS, Lui LY, Cummings SR: Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001;86:631-637.
27. Stenvenkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutricion, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
28. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001;12:814-821.
29. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM: C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002;62:1417-1422.
30. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 2005;67:1216-1233.
31. Dalboni MA, Sardenberg C, Andreoli MC, Watanabe R, Canziani ME, Santos BF, Liangos O, Jaber BL, Draibe S, Cendoroglo M: Soluble Fas: a novel marker of inflammation in uremia. Artif Organs 2003;27:687-691.
32. Hebert MJ, Masse M, Vigneault N, Sirois I, Troyanov S, Madore F: Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease. Am J Kidney Dis 2001;38:1271-1276.
33. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998;281:1305-1308.
34. Libby P: Changing concepts of atherogenesis. J Intern Med 2000;247:349-358.
35. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P: Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2200-2208.
36. Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL: Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure. J Lab Clin Med 2000;136:320-327.
37. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
38. Salomon RG, Kaur K, Podrez E, Hoff HF, Krushinsky AV, Sayre LM: HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and arepresent in atherosclerotic plaques. Chem Res Toxicol 2000;13:557-564.
39. Ozdemir FN, Guz G, Haberal M: Atherosclerosis risk is higer in continuous ambulatory peritoneal dialysis patient than in hemodialysis patients. Artif Organs 2001;25:448-452.